Clinical Trial Update: Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety of Org 50081 (Esmirtazapine) in elderly with insomnia-related disorders; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyssomnias
• Insomnia
• Mental Disorders
• Sleep Disorders
• Sleep Initiation and Maintenance Disorders

Drugs mentioned

• Org 50081

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia, Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED | Results posted: 2014-08-05